First Acceptance (FAC) Tough quarter for auto insurer. Drops to $4.94 from 52-week high of $11.77.
Bowater Incorporated (BOW) Loses abitration with Weyerhause. Down to 14.60 from 52-week high of $29.96. Business combination with Abitibi approved.
Abitibi-Price (ABY) Shareholders seem unhappy with marriage with Bowater. Down to $1.72 from 52-week high of $3.51.
Harley-Davidson (HOG) Bad numbers continue to dog the hog. Down to $46.35 from 52-week high of $75.87.
ACE*COMM (ACEC) Delisted from Nasdaq. Falls to $.42 from 52-week high of $1.92.
Neurobiological Technologies (NTII) Loss in last quarter. Drops to $.57 from 52-week high of $3.22.
Encysive Pharmaceuticals (ENCY) Biopharma drops to $1.46 from 52-week high of $7.10.
Douglas A. McIntyre
In 20 Years, I Haven’t Seen A Cash Back Card This Good
After two decades of reviewing financial products I haven’t seen anything like this. Credit card companies are at war, handing out free rewards and benefits to win the best customers.
A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges.
Our top pick today pays up to 5% cash back, a $200 bonus on top, and $0 annual fee. Click here to apply before they stop offering rewards this generous.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.